Literature DB >> 283321

Findings in computerized axial tomography after intrathecal methotrexate and radiation.

H Arnold, D Kühne, H Franke, I Grosch.   

Abstract

Medulloblastoma and acute lymphocytic leukemia patients treated by intrathecal methotrexate and radiation were investigated by means of computerized axial tomography. More than 50% of them turned out to have acquired encephalopathy. Only gross morphologic brain defects, as visualized by computerized tomography, caused manifest clinical signs of brain dysfunction, such as epilepsy, mental retardation, paresis, and apallic syndrome. Mild morphologic changes were found even in asymptomatic children. The preferred site of defects in brain substance was the paraventricular white matter.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 283321     DOI: 10.1007/bf00395205

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  13 in total

1.  Cerebral calcifications associated with intrathecal methotrexate therapy in acute lymphocytic leukemia.

Authors:  S Mueller; W Bell; J Seibert
Journal:  J Pediatr       Date:  1976-04       Impact factor: 4.406

2.  Intracerebral calcifications appearing during the course of acute lymphocytic leukemia treated with methotrexate and X-rays.

Authors:  J Flament-Durand; P Ketelbant-Balasse; R Maurus; R Regnier; M Spehl
Journal:  Cancer       Date:  1975-02       Impact factor: 6.860

3.  [Indications for radiotherapy of acute leukemia in children with special reference to clinically non-manifest involvement of CNS].

Authors:  H D Franke; G Landbeck; J Timmermann; K Winkler
Journal:  Strahlentherapie       Date:  1974-02

4.  Proceedings: Parenchymatous degeneration of the central nervous system in childhood leukemia.

Authors:  B Hendin; D C DeVivo; R Torack; M E Lell; A H Ragab; T J Vietti
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

5.  Encephalopathy in acute leukaemia associated with methotrexate therapy.

Authors:  H E Kay; P J Knapton; J P O'Sullivan; D G Wells; R F Harris; E M Innes; J Stuart; F C Schwartz; E N Thompson
Journal:  Arch Dis Child       Date:  1972-06       Impact factor: 3.791

6.  Leukoencephalopathy following the administration of methotrexate into the cerebrospinal fluid in the treatment of primary brain tumors.

Authors:  H Norrell; C B Wilson; D E Slagel; D B Clark
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

7.  Necrotizing encephalopathy following intraventricular instillation of methotrexate.

Authors:  W R Shapiro; N L Chernik; J B Posner
Journal:  Arch Neurol       Date:  1973-02

8.  Direct administration of methotrexate into the central nervous system of primates. Part 1: Distribution and degradation of methotrexate in nervous and systemic tissue after intraventricular injection.

Authors:  H K Kimelberg; D Kung; R E Watson; F L Reiss; S M Biddlecome; R S Bourke
Journal:  J Neurosurg       Date:  1978-06       Impact factor: 5.115

9.  Effects of chemotherapy on the central nervous system. A study of parenteral methotrexate in long-term survivors of leukemia and lymphoma in childhood.

Authors:  A T Meadows; A E Evans
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

10.  Computer assisted tomography in methotrexate encephalopathy.

Authors:  N Peylan-Ramu; D G Poplack; C L Blei; J R Herdt; M Vermess; G Di Chiro
Journal:  J Comput Assist Tomogr       Date:  1977-04       Impact factor: 1.826

View more
  2 in total

1.  CT studies before and after CNS treatment for acute lymphoblastic leukemia and malignant non-hodgkin's lymphoma in childhood.

Authors:  K Kretzschmar; P Gutjahr; J Kutzner
Journal:  Neuroradiology       Date:  1980-12       Impact factor: 2.804

2.  The development of cerebral CT changes during treatment of acute lymphocytic leukemia in childhood.

Authors:  H Pedersen; N Clausen
Journal:  Neuroradiology       Date:  1981       Impact factor: 2.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.